Infographics - ASCVD & Lipidology Knowledge Hub

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm
  • Share

  • Stay up to date
  • Home
  • Topics
    • Cardiovascular Diseases and Conditions
      • Acute Coronary Syndrome
      • ASCVD
      • Atherosclerosis
      • Coronary artery disease
      • CVD
      • ASCVD
      • Myocardial Infarction
    • Lipid Metabolism and Disorders
      • Lipids
        • PUFA
          • Eicosanoids
      • Cholesterol
        • High-density lipoprotein
        • Low-density lipoprotein
        • Low-density Lipoprotein Cholesterol
        • Lipoprotein (a)
        • Apolipoprotein B
        • Hypercholesterolemia
        • Hyperlipidemia
        • Dyslipidemia
        • Familial hypercholesterolemia
      • Triglycerides
      • Cholesterol synthesis
      • Cholesterol absorption
    • Medications and Therapies
      • Therapy
      • Lipid lowering therapy
        • Statin
          • High-intensity statin
        • PCSK9
          • Alirocumab
          • Evolocumab
        • Bempedoic acid
        • Icosapent Ethyl
        • Inclisiran
        • Obicetrapib
        • Zerlasiran
      • Combination therapy
      • Aspirin
      • Immunotherapy
      • Short interfering RNA (siRNA)
      • Diabetes
    • Risk Factors and Prevention
      • CVD Risk Factor
      • Primary prevention
      • Prevention
      • Risk assessment
      • Women
      • Inflammation
      • Calcium Scoring
      • Models
    • Clinical Research and Guidelines
      • Clinical Trial
      • Trials
      • Guidelines
      • Consensus statement
      • Registry
      • GOULD
      • Long-term studies
      • Case Studies
    • Other Related Topics
      • Congresses
      • Global health
      • Vaccination
        • Influenza
      • Non-adherence
      • Pediatric Population
      • Plaques
      • Obesity
    • Molecular and Genetic Factors
      • ANGPTL3
      • Pharmacogenomics
  • Webinars/Videos
  • Infographics
  • Articles
  • Case Studies
  • Forum
  • Faculty
  • Unblocked
  • Stay up to date

Guidelines Infographics

  • Infographics

    World Heart Federation’s 2022 Roadmap – A Framework for the Management and Prevention of ASCVD

    This infographic summarizes the key take home messages of the World Heart Federation’s Cholesterol Roadmap.

    First published: March 3, 2023  

    View
    • Share

  • Infographics

    Role of Nonstatin Therapies in Lowering LDL-Cholesterol during Atherosclerotic Cardiovascular Disease Risk Management

    Check out and download our latest infographic based on the 2022 Expert Consensus Decision Pathway by the American College of Cardiology – Role of Nonstatin Therapies in Lowering LDL-Cholesterol during ASCVD Risk Management.

    First published: November 3, 2022  

    View
    • Share

  • Infographics

    Lipid Measurement Recommendations in CVD: Key Take Home Messages

    This infographic summarizes the key takeaway messages from the recently published National Lipid Association (NLA) Scientific Statement on Lipid Measurements in the Management of Cardiovascular Diseases.

    First published: October 21, 2021  

    View
    • Share

  • Infographics

    ESC 2021 Guidelines on CVD Prevention: Key Takeaways on ASCVD and Lipid Management

    There was a lot to process from the latest ESC guidance on CVD prevention. This infographic focusses on the key updates in ASCVD and lipidology, which revolved around the importance of risk assessment and the best time to initiate treatment.

    First published: September 16, 2021  

    View
    • Share

How would you rate this content?

  • © John Wiley & Sons, Ltd. All rights reserved.
  • Privacy Policy
  • Terms of use
  • Stay up to date
  • Cookie Preferences
  • This Knowledge Hub is supported by Novartis.
Clinical Cardiology